These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12729838)

  • 1. Loss of anti-cataleptic effect of scopolamine in mice lacking muscarinic acetylcholine receptor subtype 4.
    Karasawa H; Taketo MM; Matsui M
    Eur J Pharmacol; 2003 May; 468(1):15-9. PubMed ID: 12729838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor.
    Fink-Jensen A; Schmidt LS; Dencker D; Schülein C; Wess J; Wörtwein G; Woldbye DP
    Eur J Pharmacol; 2011 Apr; 656(1-3):39-44. PubMed ID: 21269601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M
    Joseph L; Thomsen M
    Behav Brain Res; 2017 Jun; 329():75-83. PubMed ID: 28442355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of prepulse inhibition through both M(1) and M (4) muscarinic receptors in mice.
    Thomsen M; Wess J; Fulton BS; Fink-Jensen A; Caine SB
    Psychopharmacology (Berl); 2010 Feb; 208(3):401-16. PubMed ID: 20013114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of muscarinic acetylcholine receptors facilitates motivated behaviour and rescues a model of antipsychotic-induced amotivation.
    Hailwood JM; Heath CJ; Phillips BU; Robbins TW; Saksida LM; Bussey TJ
    Neuropsychopharmacology; 2019 May; 44(6):1068-1075. PubMed ID: 30478410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of M3-choline receptor blockade on the ability of muscarinic antagonists to prevent catalepsy induced by haloperidol in rats].
    Kosmachev AB; Beliaev VA; Khrabrova AV; Libman NM; Dolgo-Saburov VB
    Eksp Klin Farmakol; 2001; 64(4):10-2. PubMed ID: 11589099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic agonist-mediated increases in serum corticosterone levels are abolished in m(2) muscarinic acetylcholine receptor knockout mice.
    Hemrick-Luecke SK; Bymaster FP; Evans DC; Wess J; Felder CC
    J Pharmacol Exp Ther; 2002 Oct; 303(1):99-103. PubMed ID: 12235238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potency and efficacy of anticholinergics to inhibit haloperidol-induced catalepsy in rats correlates with their rank order of affinities for the muscarinic receptor subtypes.
    Erosa-Rivero HB; Bata-García JL; Alvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL
    Neuropharmacology; 2014 Jun; 81():176-87. PubMed ID: 24534110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cholingeric drugs on methadone-induced catalepsy and stereotypies in rats treated chronically with methadone.
    Ahtee L
    Eur J Pharmacol; 1976 Oct; 39(2):203-13. PubMed ID: 987911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats.
    Mandhane SN; Chopde CT; Ghosh AK
    Eur J Pharmacol; 1997 Jun; 328(2-3):135-41. PubMed ID: 9218695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of M2 and M4 muscarinic receptors in regulating acetylcholine release from myenteric neurons of mouse ileum.
    Takeuchi T; Fujinami K; Goto H; Fujita A; Taketo MM; Manabe T; Matsui M; Hata F
    J Neurophysiol; 2005 May; 93(5):2841-8. PubMed ID: 15574798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.
    Kaakkola S; Ahtee L
    Psychopharmacology (Berl); 1977 Mar; 52(1):7-15. PubMed ID: 403561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
    Onodera K; Shinoda H
    Agents Actions; 1991 May; 33(1-2):143-6. PubMed ID: 1897431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice.
    Gomeza J; Zhang L; Kostenis E; Felder C; Bymaster F; Brodkin J; Shannon H; Xia B; Deng C; Wess J
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10483-8. PubMed ID: 10468635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
    Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
    Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics.
    Arnt J; Christensen AV
    Eur J Pharmacol; 1981 Jan; 69(1):107-11. PubMed ID: 6110555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scopolamine attenuates haloperidol-induced c-fos expression in the striatum.
    Guo N; Robertson GS; Fibiger HC
    Brain Res; 1992 Aug; 588(1):164-7. PubMed ID: 1393566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice.
    Tzavara ET; Bymaster FP; Felder CC; Wade M; Gomeza J; Wess J; McKinzie DL; Nomikos GG
    Mol Psychiatry; 2003 Jul; 8(7):673-9. PubMed ID: 12874603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locomotion and stereotypy induced by scopolamine: contributions of muscarinic receptors near the pedunculopontine tegmental nucleus.
    Mathur A; Shandarin A; LaViolette SR; Parker J; Yeomans JS
    Brain Res; 1997 Nov; 775(1-2):144-55. PubMed ID: 9439838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.